|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH |
D Brown, Medicine, Charles Drew university, Los Angeles, United States
A Sina-Hikim, Endocrinology, LABiomed Harbor UCLA David Geffen School of Medicine, Torrance, United States
E Kovacheva, Medicine, Charles Drew university, Los Angeles, United States
I Sinha-Hikim, Medicine, Div: Endocrinology, Charles Drew University, Los Angeles, 90059, United States
Correspondence: Indrani Sinha-Hikim, Email: insinhah{at}cdrewu.edu
Abstract
As a prerequisite for studies using mutant mice, we established a mouse model for investigating the molecular mechanisms by which testosterone (T) promotes muscle growth.
Adult mice (C57BL/6) received one of the following treatments: 1) vehicle (sterile distilled water; normal control) and 2) gonadotropin-releasing hormone antagonist (GnRH-A) with empty (sham control) or 2 cm T- filled implant. Mice were killed 2, 6, and 8 wk after treatment. T treatment for 8 wk resulted in a significant (P<0.001) increase in fiber area of gastrocnemius muscles. T-induced fiber-hypertrophy was accompanied by up-regulation of the Notch ligand Delta 1 and activation of Notch signaling, as evidenced by increase in activated forms of Notch 1 and Notch 2. We also observed an increase in the number of PCNA-positive nuclei in muscles of T-treated mice, indicating that activation of Notch signaling enhanced cell proliferation. T supplementation not only triggered p38 MAPK activation but also concurrently inhibited c-Jun NH2-terminal kinase (JNK) activation with 2 wk of treatment. Concomitant administration of SB203580, a p38 MAPK inhibitor, effectively blocked T-induced activation of Notch signaling and significantly (P<0.001) suppressed PCNA levels. Together, our results indicate that T induces muscle fiber hypertrophy through activation of Notch-signaling and the inactivation of JNK together with the activation of p38 MAPK may be critical for T-induced activation of Notch signaling and, as a consequence, muscle fiber hypertrophy.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |